Effective Treatment for Mental and Substance Use Disorders in 21 Countries

Daniel V. Vigo 1, 2, 3
Dan J. Stein 4, 5
Meredith G. Harris 6, 7
Alan E. Kazdin 8
Richard Munthali 1
Lonna Munro 1
Irving Hwang 9
Timothy L Kessler 10
Sophie M. Manoukian 9
Nancy A. Sampson 9
Ronald C. Kessler 9
Sergio Aguilar-Gaxiola 11
Jordi Alonso 11
Laura Helena Andrade 11
Corina Benjet 11
Guilherme Borges 11
Ronny Bruffaerts 11
Brendan Bunting 11
José Miguel Caldas-de-Almeida 11
Graça Cardoso 11
Alfredo H. Cía 11
Giovanni de Girolamo 11
Ymkje Anna de Vries 11
Oye Gureje 11
Josep Maria Haro 11
Hristo Hinkov 11
Aimee Nasser Karam 11
Elie G. Karam 11
Georges Karam 11
Norito Kawakami 11
Andrzej Kiejna 11
Viviane Kovess-Masfety 11
Maria Elena Medina-Mora 11
Jacek Moskalewicz 11
Fernando Navarro-Mateu 11
Daisuke Nishi 11
Marina Piazza 11
José Posada-Villa 11
Annelieke Roest 11
Juan Carlos Stagnaro 11
Margreet ten Have 11
Yolanda Torres 11
Maria Carmen Viana 11
Cristian Vladescu 11
David R. Williams 11
Bogdan Wojtyniak 11
Miguel Xavier 11
Publication typeJournal Article
Publication date2025-02-05
scimago Q1
wos Q1
SJR5.755
CiteScore31.4
Impact factor17.1
ISSN2168622X, 21686238
Abstract
Importance

Accurate baseline information about the proportion of people with mental disorders who receive effective treatment is required to assess the success of treatment quality improvement initiatives.

Objective

To examine the proportion of mental and substance use disorders receiving guideline-consistent treatment in multiple countries.

Design, Setting, and Participants

In this cross-sectional study, World Mental Health (WMH) surveys were administered to representative adult (aged 18 years and older) household samples in 21 countries. Data were collected between 2001 and 2019 and analyzed between February and July 2024. Twelve-month prevalence and treatment of 9 DSM-IV anxiety, mood, and substance use disorders were assessed with the Composite International Diagnostic Interview. Effective treatment and its components were estimated with cross-tabulations. Multilevel regression models were used to examine predictors.

Main Outcomes and Measures

The main outcome was proportion of effective treatment received, defined at the disorder level using information about disorder severity and published treatment guidelines regarding adequate medication type, control, and adherence and adequate psychotherapy frequency. Intermediate outcomes included perceived need for treatment, treatment contact separately in the presence and absence of perceived need, and minimally adequate treatment given contact. Individual-level predictors (multivariable disorder profile, sex, age, education, family income, marital status, employment status, and health insurance) and country-level predictors (treatment resources, health care spending, human development indicators, stigma, and discrimination) were traced through intervening outcomes.

Results

Among the 56 927 respondents (69.3% weighted average response rate), 32 829 (57.7%) were female; the median (IQR) age was 43 (31-57) years. The proportion of 12-month person-disorders receiving effective treatment was 6.9% (SE, 0.3). Low perceived need (46.5%; SE, 0.6), low treatment contact given perceived need (34.1%; SE, 1.0), and low effective treatment given minimally adequate treatment (47.0%; SE, 1.7) were the major barriers, but with substantial variation across disorders. Country-level general medical treatment resources were more important than mental health treatment resources. Other than for the multivariable disorder profile, which was associated with all intermediate outcomes, significant predictors were largely mediated by treatment contact.

Conclusions and Relevance

In addition to the gaps in treatment quality, these results highlight the importance of increasing perceived need, the largest barrier to effective treatment; the importance of training primary care treatment clinicians in recognition and treatment of mental disorders; the need to improve the continuum of care, especially from minimally adequate to effective treatment; and the importance of bridging the effective treatment gap for men and people with lower education.

Found 
Found 

Top-30

Journals

1
Healthcare
1 publication, 25%
International Journal of Mental Health Systems
1 publication, 25%
Clinical Psychology Review
1 publication, 25%
Neuropsychiatrie
1 publication, 25%
1

Publishers

1
2
Springer Nature
2 publications, 50%
MDPI
1 publication, 25%
Elsevier
1 publication, 25%
1
2
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
5
Share
Cite this
GOST |
Cite this
GOST Copy
Vigo D. V. et al. Effective Treatment for Mental and Substance Use Disorders in 21 Countries // JAMA Psychiatry. 2025.
GOST all authors (up to 50) Copy
Vigo D. V. et al. Effective Treatment for Mental and Substance Use Disorders in 21 Countries // JAMA Psychiatry. 2025.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1001/jamapsychiatry.2024.4378
UR - https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2829593
TI - Effective Treatment for Mental and Substance Use Disorders in 21 Countries
T2 - JAMA Psychiatry
AU - Vigo, Daniel V.
AU - Stein, Dan J.
AU - Harris, Meredith G.
AU - Kazdin, Alan E.
AU - Munthali, Richard
AU - Munro, Lonna
AU - Hwang, Irving
AU - Kessler, Timothy L
AU - Manoukian, Sophie M.
AU - Sampson, Nancy A.
AU - Kessler, Ronald C.
AU - Aguilar-Gaxiola, Sergio
AU - Alonso, Jordi
AU - Andrade, Laura Helena
AU - Benjet, Corina
AU - Borges, Guilherme
AU - Bruffaerts, Ronny
AU - Bunting, Brendan
AU - Caldas-de-Almeida, José Miguel
AU - Cardoso, Graça
AU - Cía, Alfredo H.
AU - de Girolamo, Giovanni
AU - de Vries, Ymkje Anna
AU - Gureje, Oye
AU - Haro, Josep Maria
AU - Hinkov, Hristo
AU - Karam, Aimee Nasser
AU - Karam, Elie G.
AU - Karam, Georges
AU - Kawakami, Norito
AU - Kiejna, Andrzej
AU - Kovess-Masfety, Viviane
AU - Medina-Mora, Maria Elena
AU - Moskalewicz, Jacek
AU - Navarro-Mateu, Fernando
AU - Nishi, Daisuke
AU - Piazza, Marina
AU - Posada-Villa, José
AU - Roest, Annelieke
AU - Stagnaro, Juan Carlos
AU - ten Have, Margreet
AU - Torres, Yolanda
AU - Viana, Maria Carmen
AU - Vladescu, Cristian
AU - Williams, David R.
AU - Wojtyniak, Bogdan
AU - Xavier, Miguel
PY - 2025
DA - 2025/02/05
PB - American Medical Association (AMA)
SN - 2168-622X
SN - 2168-6238
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2025_Vigo,
author = {Daniel V. Vigo and Dan J. Stein and Meredith G. Harris and Alan E. Kazdin and Richard Munthali and Lonna Munro and Irving Hwang and Timothy L Kessler and Sophie M. Manoukian and Nancy A. Sampson and Ronald C. Kessler and Sergio Aguilar-Gaxiola and Jordi Alonso and Laura Helena Andrade and Corina Benjet and Guilherme Borges and Ronny Bruffaerts and Brendan Bunting and José Miguel Caldas-de-Almeida and Graça Cardoso and Alfredo H. Cía and Giovanni de Girolamo and Ymkje Anna de Vries and Oye Gureje and Josep Maria Haro and Hristo Hinkov and Aimee Nasser Karam and Elie G. Karam and Georges Karam and Norito Kawakami and Andrzej Kiejna and Viviane Kovess-Masfety and Maria Elena Medina-Mora and Jacek Moskalewicz and Fernando Navarro-Mateu and Daisuke Nishi and Marina Piazza and José Posada-Villa and Annelieke Roest and Juan Carlos Stagnaro and Margreet ten Have and Yolanda Torres and Maria Carmen Viana and Cristian Vladescu and David R. Williams and Bogdan Wojtyniak and Miguel Xavier and others},
title = {Effective Treatment for Mental and Substance Use Disorders in 21 Countries},
journal = {JAMA Psychiatry},
year = {2025},
publisher = {American Medical Association (AMA)},
month = {feb},
url = {https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2829593},
doi = {10.1001/jamapsychiatry.2024.4378}
}